PYRIMETHAMINE Drug Patent Profile
✉ Email this page to a colleague
Which patents cover Pyrimethamine, and what generic alternatives are available?
Pyrimethamine is a drug marketed by Alvogen, Aurobindo Pharma Ltd, Sanaluz, and Teva Pharms. and is included in four NDAs.
The generic ingredient in PYRIMETHAMINE is pyrimethamine. There are three drug master file entries for this compound. Eight suppliers are listed for this compound. Additional details are available on the pyrimethamine profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Pyrimethamine
A generic version of PYRIMETHAMINE was approved as pyrimethamine by SANALUZ on February 28th, 2020.
AI Research Assistant
Questions you can ask:
- What is the 5 year forecast for PYRIMETHAMINE?
- What are the global sales for PYRIMETHAMINE?
- What is Average Wholesale Price for PYRIMETHAMINE?
Summary for PYRIMETHAMINE
| US Patents: | 0 |
| Applicants: | 4 |
| NDAs: | 4 |
| Finished Product Suppliers / Packagers: | 5 |
| Raw Ingredient (Bulk) Api Vendors: | 128 |
| Clinical Trials: | 222 |
| Patent Applications: | 3,840 |
| Drug Prices: | Drug price information for PYRIMETHAMINE |
| What excipients (inactive ingredients) are in PYRIMETHAMINE? | PYRIMETHAMINE excipients list |
| DailyMed Link: | PYRIMETHAMINE at DailyMed |
Recent Clinical Trials for PYRIMETHAMINE
Identify potential brand extensions & 505(b)(2) entrants
| Sponsor | Phase |
|---|---|
| Kamuzu University of Health Sciences | Phase 4 |
| Malaria Consortium | Phase 3 |
| Washington University School of Medicine | Early Phase 1 |
Pharmacology for PYRIMETHAMINE
| Drug Class | Dihydrofolate Reductase Inhibitor Antimalarial |
| Mechanism of Action | Dihydrofolate Reductase Inhibitors |
Medical Subject Heading (MeSH) Categories for PYRIMETHAMINE
Anatomical Therapeutic Chemical (ATC) Classes for PYRIMETHAMINE
US Patents and Regulatory Information for PYRIMETHAMINE
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Alvogen | PYRIMETHAMINE | pyrimethamine | TABLET;ORAL | 211271-001 | Jul 27, 2021 | AB | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | |||
| Teva Pharms | PYRIMETHAMINE | pyrimethamine | TABLET;ORAL | 215506-001 | Aug 13, 2021 | AB | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | |||
| Aurobindo Pharma Ltd | PYRIMETHAMINE | pyrimethamine | TABLET;ORAL | 216983-001 | Oct 25, 2022 | AB | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | |||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
